Evidence map›Paper›PMID 35277414›Full record

ArticleBMJ open2022

Use of selective gut decontamination in critically ill children: protocol for the Paediatric Intensive Care and Infection Control (PICnIC) pilot study.

Alanna Brown, Paloma Ferrando, Mariana Popa, Gema Milla de la Fuente, John Pappachan, Brian Cuthbertson, Laura Drikite, Richard Feltbower, Theodore Gouliouris, Isobel Sale and 8 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Alanna BrownIntensive Care National Audit and Research Centre, London, UK.
Paloma FerrandoIntensive Care National Audit and Research Centre, London, UK.
Mariana PopaInstitute of Life and Human Sciences, University of Liverpool, Liverpool, UK.
Gema Milla de la FuenteIntensive Care National Audit and Research Centre, London, UK.
John PappachanPICU, Southampton Children's Hospital, Southampton, UK.
Brian CuthbertsonDepartment of Critical Care, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Laura DrikiteClinical Trials Unit, Intensive Care National Audit and Research Centre, London, UK.
Richard FeltbowerUniversity of Leeds, Leeds, UK.
Theodore GouliourisDepartment of Medicine, Cambridge University, Cambridge, UK.
Isobel SalePPI representative, UK, UK.
Robert ShulmanDepartment of Pharmacy, University College London Hospitals NHS Foundation Trust, London, UK.
Lyvonne N TumeSchool of Health and Society, University of Salford, Salford, UK.
John MyburghThe George Institute for Global Health, Newtown, New South Wales, Australia.
Kerry WoolfallUniversity of Liverpool, Liverpool, UK.
David A HarrisonIntensive Care National Audit and Research Centre, London, UK.ORCID 0000-0002-9002-9098
Paul R MounceyIntensive Care National Audit and Research Centre, London, UK.
Kathryn M RowanIntensive Care National Audit and Research Centre, London, UK.
Nazima PathanDepartment of Paediatrics, University of Cambridge, Cambridge, UK np409@cam.ac.uk.ORCID 0000-0001-7656-9453
Intensive Care National Audit & Research Centre · GBUniversity of Cambridge · GBUniversity of Liverpool · GBSouthampton Children's Hospital · GBSunnybrook Health Science Centre · CAThe George Institute for Global Health · AUUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Leeds · GBUniversity of Salford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHealthcare-associated infections (HCAIs) are a major cause of morbidity and mortality in critically ill children. In critically ill adults, there are data that suggest the use of Selective Decontamination of the Digestive tract (SDD), alongside standard infection control measures reduce mortality and the incidence of HCAIs. SDD-enhanced infection control has not been compared directly with standard infection prevention strategies in the Paediatric Intensive Care Unit (PICU) population. The aim of this pilot study is to determine the feasibility of conducting a multicentre cluster randomised controlled trial (cRCT) in critically ill children comparing SDD with standard infection control. METHODS AND ANALYSIS: Paediatric Intensive Care and Infection Control is a parallel group pilot cRCT, with integrated mixed-methods study, comparing incorporation of SDD into infection control procedures to standard care. After a 1-week pretrial ecology surveillance period, recruitment to the cRCT will run for a period of 18 weeks, comprising: (1) baseline control period (2) pre, mid and post-trial ecology surveillance periods and (3) intervention period. Six PICUs (in England, UK) will begin with usual care in period 1, then will be randomised 1:1 by the trial statistician using computer-based randomisation, to either continue to deliver usual care or commence delivery of the intervention (SDD) in period 2. Outcomes measures include parent and healthcare professionals' views on trial feasibility, adherence to the SDD intervention, estimation of recruitment rate and understanding of potential patient-centred primary and secondary outcome measures for the definitive trial. The planned recruitment for the cRCT is 324 participants. ETHICS AND DISSEMINATION: The trial received favourable ethical opinion from West Midlands-Black Country Research Ethics Committee (reference: 20/WM/0061) and approval from the Health Research Authority (IRAS number: 239324). Informed consent is not required for SDD intervention or anonymised data collection but is sought for investigations as part of the study, any identifiable data collected and monitoring of medical records. Results will be disseminated via publications in peer-reviewed medical journals. TRIAL REGISTRATION NUMBER: ISRCTN40310490.

Indexed as

Critical IllnessCross InfectionAdultChildCritical CareDecontaminationHumansInfection ControlMulticenter Studies as TopicPilot ProjectsRandomized Controlled Trials as Topicinfection controlmicrobiologypaediatric intensive & critical care

Identifiers

PMID35277414
PMCPMC8919465
OpenAlexW4220937526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.